1. Rustum, Y., et al. Biochemical and pharmacologic basis for potentiation of fluorouracil action by lecuovorin. NCI Monogr. 5:165, 1987.
2. Doroshow, J.H., Multhauf, P., Leong, L., Margolin, K., Litchfield, T., Akman, S., Carr, B., Bertrand, M., Goldberg, D., Blayney, D., Odujinrin, O., DeLap, R., Shuster, J., and Newman, E. J. Clin. Oncol. 8:491–501, 1990.
3. Dreyfuss, A.I., Clark, J.R., Wright, J.E., Norris, CM. Jr., Busse, P.M., Lacarini, J.W., Fallon, G.B., Casey, D., Anderson, J.W., Klein, R., Rosowsky, A., Miller, D., and Frei, E. III. Continuous infusion high-dose leucovorin with 5-fluorouracil and cisplatin for untreated stage IV carcinoma of the head and neck. Ann. Intern. Med. 112:167–172, 1990.
4. DeVita, V.T., Hellman, S., and Rosenberg, S.A. Cancer: Principles and Practice of Oncology, 3rd ed. J.B. Lippincott, Philadelphia, 1989.
5. Teicher, B.A., Cucchi, C.A., Lee, J.B., Flatow, J.L., Rosowsky, A., and Frei, E. III. Alkylating agents: in vitro studies of cross-resistance patterns. Cancer Res. 46:4379–4383, 1986.